Literature DB >> 16155725

Direct evidence of host genome acquisition by the alphaherpesvirus Marek's disease virus.

M Niikura1, J Dodgson, H Cheng.   

Abstract

Many herpesviruses including Marek's disease virus (MDV), a poultry alphaherpesvirus, carry homologous host genes presumably acquired during viral evolution. We have characterized one recent acquisition by MDV in considerable detail. The virulent MDV strain Md11 previously was isolated from a commercial chicken and initially propagated on duck cells. In the process of cloning the entire Md11 genome in a bacterial artificial chromosome (BAC), we obtained an infectious clone in which the entire terminal repeat short segment was replaced with a portion of the duck genome that corresponds to chicken chromosome 19. This sequence is not predicted to express any protein even though it contains one exon of the VAMP1 gene. The replacement did not affect MDV replication in vitro, despite the virus having only one copy of ICP4. Furthermore, we have shown that the variant MDV genome containing the duck genome substitution is present in the parental Md11 population and has been maintained through several subsequent propagations of the virus on chicken cells. This finding provides direct evidence that host genome acquisition by MDV actually occurs during virus replication, and that one or more such MDV genomes with host sequences may exist within MDV viral stocks which tend to be polyclonal, due to the cell-associated nature of its infection process.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16155725     DOI: 10.1007/s00705-005-0633-7

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  19 in total

1.  Herpesvirus systematics.

Authors:  Andrew J Davison
Journal:  Vet Microbiol       Date:  2010-02-11       Impact factor: 3.293

2.  Comparative sequence analysis of a highly oncogenic but horizontal spread-defective clone of Marek's disease virus.

Authors:  Stephen J Spatz; Yuguang Zhao; Lawrence Petherbridge; Lorraine P Smith; Susan J Baigent; Venugopal Nair
Journal:  Virus Genes       Date:  2007-08-25       Impact factor: 2.332

3.  Clustering of mutations within the inverted repeat regions of a serially passaged attenuated gallid herpesvirus type 2 strain.

Authors:  Stephen J Spatz; Cary Rue; Daniel Schumacher; Nikolaus Osterrieder
Journal:  Virus Genes       Date:  2008-05-31       Impact factor: 2.332

4.  Genome sequence determination and analysis of a Chinese virulent strain, LMS, of Gallid herpesvirus type 2.

Authors:  Yun Cheng; Feng Cong; Yan-ping Zhang; Zhi-jie Li; Na-na Xu; Guang-yu Hou; Chang-Jun Liu
Journal:  Virus Genes       Date:  2012-04-04       Impact factor: 2.332

5.  Marek's disease viruses lacking either R-LORF10 or LORF4 have altered virulence in chickens.

Authors:  Taejoong Kim; Henry D Hunt; Hans H Cheng
Journal:  Virus Genes       Date:  2010-03-13       Impact factor: 2.332

6.  An MHC class I immune evasion gene of Marek׳s disease virus.

Authors:  Cari Hearn; Likit Preeyanon; Henry D Hunt; Ian A York
Journal:  Virology       Date:  2014-11-27       Impact factor: 3.616

7.  Sequence determination of a mildly virulent strain (CU-2) of Gallid herpesvirus type 2 using 454 pyrosequencing.

Authors:  Stephen J Spatz; Cary A Rue
Journal:  Virus Genes       Date:  2008-03-20       Impact factor: 2.332

8.  Visualization of Marek's disease virus in vitro using enhanced green fluorescent protein fused with US10.

Authors:  Weifeng Mao; Taejoong Kim; Hans H Cheng
Journal:  Virus Genes       Date:  2013-05-24       Impact factor: 2.332

9.  Phylogeny and recombination history of gallid herpesvirus 2 (Marek's disease virus) genomes.

Authors:  Austin L Hughes; Pierre Rivailler
Journal:  Virus Res       Date:  2007-06-12       Impact factor: 3.303

10.  Horizontal transmission of Marek's disease virus requires US2, the UL13 protein kinase, and gC.

Authors:  Keith W Jarosinski; Neil G Margulis; Jeremy P Kamil; Stephen J Spatz; Venugopal K Nair; Nikolaus Osterrieder
Journal:  J Virol       Date:  2007-07-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.